Nordea Investment Management AB Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Nordea Investment Management AB grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 245.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 251,556 shares of the medical instruments supplier’s stock after purchasing an additional 178,639 shares during the period. Nordea Investment Management AB owned approximately 0.13% of DENTSPLY SIRONA worth $4,754,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $27,000. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $35,000. Van ECK Associates Corp purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $42,000. Finally, Allworth Financial LP lifted its holdings in shares of DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $18.12 on Friday. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $37.35. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $3.60 billion, a PE ratio of -8.75, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The stock’s 50-day moving average price is $19.27 and its 200-day moving average price is $23.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the previous year, the firm posted $0.49 EPS. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.53%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s payout ratio is -30.92%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Morgan Stanley cut their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Mizuho assumed coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price on the stock. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $27.27.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.